Diligence memo · auto-generated · as of July 2, 2026

Stemcell Technologies

Stemcell Technologies: limited disclosed financing to assess.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

Stemcell Technologies operates in biotechnology, based in Vancouver, Canada. Canadian company, based in Vancouver. Sector: biotechnology.

Sub-sector tags: biotech, biotechnology.

Capital & rounds (filed)filed

Stemcell Technologies has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.

Valuation (modeled)modeled

No modeled valuation — too little disclosed financing to estimate one.

Financing rhythm & timingmixed

Not enough dated financing history to read a financing rhythm.

Comparablesmixed

Capital scale ranks ahead of 100% of biotechnology peers (14 compared).

Modeled value ranks above 100% of those peers.

Peoplefiled

Allen C Eaves is named as Founder in the public records.

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

No structural red flags surfaced from the public record — standard primary diligence still applies.